Note*: This report requires 7-10 business days to complete.
DelveInsight’s H1N1 (Swine Influenza) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and H1N1 (Swine Influenza) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of H1N1 (Swine Influenza) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global H1N1 (Swine Influenza) market.
• Identifying patient populations in the global “H1N1 (Swine Influenza)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for H1N1 (Swine Influenza) therapeutics in each of the markets covered.
• To understand the future market competition in the global H1N1 (Swine Influenza) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides H1N1 (Swine Influenza) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• H1N1 (Swine Influenza) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global H1N1 (Swine Influenza) Market
• Global Epidemiology of H1N1 (Swine Influenza) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: H1N1 (Swine Influenza) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of H1N1 (Swine Influenza) (2013-2023)
• Table 7: H1N1 (Swine Influenza) Global Market (USD Millions), (2013-2015)
• Table 8: H1N1 (Swine Influenza) Global Market (USD Millions), (2016-2023)
• Table 9: H1N1 (Swine Influenza) US Market (USD Millions), (2013-2015)
• Table 10: H1N1 (Swine Influenza) US Market (USD Millions), (2016-2023)
• Table 11: H1N1 (Swine Influenza) Germany Market (USD Millions), (2013-2015)
• Table 12: H1N1 (Swine Influenza) Germany Market (USD Millions), (2016-2023)
• Table 13: H1N1 (Swine Influenza) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: H1N1 (Swine Influenza) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: H1N1 (Swine Influenza) France Market (USD Millions), (2013-2015)
• Table 16: H1N1 (Swine Influenza) France Market (USD Millions), (2016-2023)
• Table 17: H1N1 (Swine Influenza) Italy Market (USD Millions), (2013-2015)
• Table 18: H1N1 (Swine Influenza) Italy Market (USD Millions), (2016-2023)
• Table 19: H1N1 (Swine Influenza) Spain Market (USD Millions), (2013-2015)
• Table 20: H1N1 (Swine Influenza) Spain Market (USD Millions), (2016-2023)
• Table 21: H1N1 (Swine Influenza) Japan Market (USD Millions), (2013-2015)
• Table 22: H1N1 (Swine Influenza) Japan Market (USD Millions), (2016-2023)
• Table 23: H1N1 (Swine Influenza) ROW Market (USD Millions), (2013-2015)
• Table 24: H1N1 (Swine Influenza) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: H1N1 (Swine Influenza) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of H1N1 (Swine Influenza) (2013-2023)
• Figure 3: H1N1 (Swine Influenza) Global Market (USD Millions), (2013-2015)
• Figure 4: H1N1 (Swine Influenza) Global Market (USD Millions), (2016-2023)
• Figure 5: H1N1 (Swine Influenza) US Market (USD Millions), (2013-2015)
• Figure 6: H1N1 (Swine Influenza) US Market (USD Millions), (2016-2023)
• Figure 7: H1N1 (Swine Influenza) Germany Market (USD Millions), (2013-2015)
• Figure 8: H1N1 (Swine Influenza) Germany Market (USD Millions), (2016-2023)
• Figure 9: H1N1 (Swine Influenza) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: H1N1 (Swine Influenza) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: H1N1 (Swine Influenza) France Market (USD Millions), (2013-2015)
• Figure 12: H1N1 (Swine Influenza) France Market (USD Millions), (2016-2023)
• Figure 13: H1N1 (Swine Influenza) Italy Market (USD Millions), (2013-2015)
• Figure 14: H1N1 (Swine Influenza) Italy Market (USD Millions), (2016-2023)
• Figure 15: H1N1 (Swine Influenza) Spain Market (USD Millions), (2013-2015)
• Figure 16: H1N1 (Swine Influenza) Spain Market (USD Millions), (2016-2023)
• Figure 17: H1N1 (Swine Influenza) Japan Market (USD Millions), (2013-2015)
• Figure 18: H1N1 (Swine Influenza) Japan Market (USD Millions), (2015-2023)
• Figure 19: H1N1 (Swine Influenza) ROW Market (USD Millions), (2013-2015)
• Figure 20: H1N1 (Swine Influenza) ROW Market (USD Millions), (2016-2023)
• Antigen Express Inc.
• CSL Limited
• EpiVax Inc.
• Etubics Corporation
• Gemmus Pharma Inc.
• Inovio Pharmaceuticals Inc.
• Johnson & Johnson.
• Kyowa Hakko Kirin Co. Ltd.
• MedImmune
• OPKO Health Inc.
• Sarepta Therapeutics Inc.
• Takeda Pharmaceutical Company Limited
• Vaxart Inc.
• Vironova AB
• Visterra Inc.
• Zydus Cadila Healthcare Limited
